Ecovyst Inc (ECVT) — closed signal from May 25, 2026
Partial Published before the outcome was known, scored automatically when the window closed on August 23, 2026 — -24.4% at the close.
Predicted vs. what happened
What happened
Reached 24% of the predicted growth at its peak, without hitting the target.
The thesis — published May 25, 2026
Ecovyst shows signs of a potential recovery: sales are improving, cash on hand is solid, and a recent acquisition could make future earnings clearer. The company noted Q1 earnings and a planned Calabrian deal that could speed a turnaround. However, losses, low trading activity and weak price momentum limit conviction; this is a watch-list setup over the next 0-3 months.
Primary drivers
- The Calabrian deal could expand the company into more specialty products
- Recent quarterly update gives clearer signs that earnings may recover
- Strong cash and liquidity reduce integration risk for the acquisition
- Demand for industrial catalysts helps diversify revenue sources
How it played out
ECVT: the 10% thesis did not play out
Lyra published ECVT at $13.81 with an expected 10% rise to $15.19. The thesis pointed to improving sales, solid cash and liquidity, the planned Calabrian acquisition, a clearer earnings picture after the Q1 update, and demand for industrial catalysts. It also noted losses, low trading activity, and weak price momentum.
The price peaked at $14.14 on May 26, a 2.4% gain. It never reached the $15.19 target. By August 23, it had fallen to $10.44. The published thesis missed within the measurement window.
What happened during the window
On June 30, Ecovyst completed its acquisition of Calabrian. On August 5, the company reported second-quarter sales growth of 42% to $250.0 million and raised its 2026 outlook.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.